NCT06907290Phase 2, phase 3Active not recruiting

A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection

Study sponsor: Mirum Pharmaceuticals, Inc. · MIRM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-05Estimated
Enrollment · participants150Estimated
Source updated2026-10-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Jun 2027. After: May 2029.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source